Its not two Buses its three…A case for CD8
Multiple Sclerosis Research,
You know the saying you wait for a bus and its a no show and then all at once two buses come along at the same time. It is like…
Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple Sclerosis
Overview of attention for article published in Neurology: Neuroimmunology and Neuroinflammation, February 2023
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (88th percentile)
-
Average Attention Score compared to outputs of the same age and source
Readers on
- mendeley
- 24 Mendeley